Des Moines Oncology Research Association

Des Moines, Iowa 50309

0 studies enrolling now · 9 studies all time

What they study most

Acute T Cell Leukemia Lymphoma, Bone Cancer, Bone Metastases, Bone Neoplasm, Breast Cancer, Breast Neoplasms, Cancer, Chemoradiotherapy-Induced Severe Oral Mucositis, Follicular Lymphoma, Locally Advanced Metastatic NSCLC, Locally Advanced Unresectable NSCLC, Malignancies

Studies at this site

• PF-07104091 as a Single Agent and in Combination Therapy — Running, not enrolling
• 9-ING-41 in Patients With Advanced Cancers — Running, not enrolling
• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
• Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma — Running, not enrolling
• Expanded Access of Sotorasib — NO_LONGER_AVAILABLE
• A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer — Stopped early
• Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) — Completed
• Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. — Stopped early
• DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer — Completed